NTLA vs VRTX
NTLA 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | NTLAINTELLIA THERAPEUTICS, INC. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | $1.46B | $120.12B |
| 市盈率(TTM) | — | 28.1 |
| 市净率 | — | 6.20 |
| 市销率 | 21.7x | — |
| 营收 | — | $12.22B(TTM) |
| 营收同比增长 | 16.9% | — |
| 净利润 | — | $4.34B(TTM) |
| 净利同比增长 | 20.5% | — |
| 每股收益(稀释) | — | $16.85(TTM) |
| 息税前利润率 | -651.7% | — |
| 净资产收益率 | -66.5% | — |
| 一年总回报 | -8.6% | — |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:NTLA vs VRTX
| 指标 | NTLA | VRTX |
|---|---|---|
| 期末价值 | $4.7K | $55.4K |
| 总回报 | -52.9% | +453.6% |
| 年化收益 (CAGR) | -7.1% | +18.2% |
| 波动率 | 78.4% | 32.8% |
| 夏普比率 | 0.25 | 0.56 |
| 索提诺比率 | 0.37 | 0.82 |
| 最大回撤 | -96.5% | -41.6% |
基于 2574 个共同交易日,2016-05-06 → 2026-08-03 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)